BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18794120)

  • 21. Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis.
    Kwon M; Rubio G; Wang H; Riedlinger G; Adem A; Zhong H; Slegowski D; Post-Zwicker L; Chidananda A; Schrump DS; Pine SR; Libutti SK
    Cancer Res Commun; 2022 Oct; 2(10):1197-1213. PubMed ID: 36860703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.
    Zimmerman MW; McQueeney KE; Isenberg JS; Pitt BR; Wasserloos KA; Homanics GE; Lazo JS
    J Biol Chem; 2014 Feb; 289(9):5904-13. PubMed ID: 24403062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.
    Garcia M; Fernandez-Garcia NI; Rivas V; Carretero M; Escamez MJ; Gonzalez-Martin A; Medrano EE; Volpert O; Jorcano JL; Jimenez B; Larcher F; Del Rio M
    Cancer Res; 2004 Aug; 64(16):5632-42. PubMed ID: 15313901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells.
    Mani M; Carrasco DE; Zhang Y; Takada K; Gatt ME; Dutta-Simmons J; Ikeda H; Diaz-Griffero F; Pena-Cruz V; Bertagnolli M; Myeroff LL; Markowitz SD; Anderson KC; Carrasco DR
    Cancer Res; 2009 Oct; 69(19):7577-86. PubMed ID: 19738061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity to TOP2 targeting chemotherapeutics is regulated by Oct1 and FILIP1L.
    Lu H; Hallstrom TC
    PLoS One; 2012; 7(8):e42921. PubMed ID: 22900064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNAzymes to mouse beta1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growth.
    Niewiarowska J; Sacewicz I; Wiktorska M; Wysocki T; Stasikowska O; Wagrowska-Danilewicz M; Cierniewski CS
    Cancer Gene Ther; 2009 Sep; 16(9):713-22. PubMed ID: 19247396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer.
    Xing X; Gu X; Ma T; Ye H
    Tumour Biol; 2015 Mar; 36(3):1773-80. PubMed ID: 25371074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
    Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
    Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
    Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
    Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
    Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA
    Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel action mechanism for MPT0G013, a derivative of arylsulfonamide, inhibits tumor angiogenesis through up-regulation of TIMP3 expression.
    Wang CY; Liou JP; Tsai AC; Lai MJ; Liu YM; Lee HY; Wang JC; Pan SL; Teng CM
    Oncotarget; 2014 Oct; 5(20):9838-50. PubMed ID: 25226613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
    Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
    Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pigment epithelial-derived factor gene loaded in PLGA nanoparticles for therapy of colon carcinoma.
    Cui FY; Song XR; Li ZY; Li SZ; Mu B; Mao YQ; Wei YQ; Yang L
    Oncol Rep; 2010 Sep; 24(3):661-8. PubMed ID: 20664971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasohibin-1 suppresses colon cancer.
    Liu S; Han B; Zhang Q; Dou J; Wang F; Lin W; Sun Y; Peng G
    Oncotarget; 2015 Apr; 6(10):7880-98. PubMed ID: 25797264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFκB in colon cancer cells and xenograft tumors.
    Chen C; Liu Y; Chen Y; Xu J
    Cancer Biol Ther; 2011 Nov; 12(9):797-807. PubMed ID: 21900746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
    Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
    J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A one, two punch for liver cancer: anti-angiogenesis with a death receptor agonist.
    Plastaras JP; Kozak KR
    Cancer Biol Ther; 2009 Mar; 8(5):463-4. PubMed ID: 19276666
    [No Abstract]   [Full Text] [Related]  

  • 39. Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth.
    Liu H; Qiu Y; Pei X; Chitteti R; Steiner R; Zhang S; Jin ZG
    Sci Rep; 2020 Nov; 10(1):20493. PubMed ID: 33235311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.
    Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL
    Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.